Patents by Inventor Peter Gunning

Peter Gunning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230339866
    Abstract: The present disclosure relates generally to a class of quinazoline compounds, compositions containing the same and the therapeutic use of the compounds in the treatment of cancer.
    Type: Application
    Filed: February 1, 2021
    Publication date: October 26, 2023
    Inventors: Edna HARDEMAN, Peter GUNNING, Eleanor EIFFE
  • Publication number: 20170166555
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a proliferative disease, preferably cancer, using compounds of the invention.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 15, 2017
    Inventors: Ian James, Ian Dixon, John Feutrill, Anthony Cuzzupe, Herbert Treutlein, Jun Zeng, Tracy Nero, Peter Gunning
  • Publication number: 20170158636
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a disease or disorder, such as a proliferative disease (preferably cancer), using compounds of the invention.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 8, 2017
    Inventors: Ian James, Ian Dixon, Andrew Heaton, Eleanor Eiffe, Peter Gunning
  • Publication number: 20170152226
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a disease or disorder, such as a proliferative disease (preferably cancer), using compounds of the invention.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 1, 2017
    Inventors: Andrew Heaton, Eleanor Eiffe, Narender Pottabathini, Peter Gunning
  • Publication number: 20060263781
    Abstract: The invention relates to methods of screening for compounds that regulate the activity of cell surface proteins. The present invention relates to a method for regulating the insertion or retention of a protein, such as the cystic fibrosis transmembrane conductance regulator (CFTR), in a cell surface membrane. The invention also relates to methods for the diagnosis and treatment or prevention of diseases caused by abnormal insertion or activity of a cell surface membrane protein, such as cystic fibrosis.
    Type: Application
    Filed: March 22, 2004
    Publication date: November 23, 2006
    Inventors: Jacqueline Dalby-Payne, Edward O'Loughlin, Peter Gunning